Wei Yan
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 15
- Cancer Research top 2%
- MicroRNA in disease regulation 21
- Molecular Biology top 2%
- Extracellular vesicles in disease 18
- RNA modifications and cancer 10
- Circular RNAs in diseases 8
- Congenital heart defects research 6
- Physiology top 5%
- Alzheimer's disease research and treatments 11
- Neurology top 5%
-
- Diet, Metabolism, and Disease 9
- Co-authors
- Shuai JiangTakashi MikawaShizhen Emily WangRongqiao HeMinghui CaoRong HeYing LiuSylvia Μ. Evans
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Yan
100 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Clinical Biochemistry 446
- Cancer Research 985
- Molecular Biology 2.5k
- Physiology 688
- Neurology 188
Countries citing papers authored by Wei Yan
This map shows the geographic impact of Wei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yan more than expected).
Fields of papers citing papers by Wei Yan
This network shows the impact of papers produced by Wei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yan. The network helps show where Wei Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 20 | |
| 7 | 2022 | 56 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 9 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 153 | |
| 12 | 2019 | 9 | |
| 13 | 2018 | 44 | |
| 14 | 2018 | 24 | |
| 15 | 2018 | 16 | |
| 16 | 2017 | 5 | |
| 17 | 2014 | 24 | |
| 18 | 2011 | 17 | |
| 19 | 2011 | 37 | |
| 20 | 2009 | 177 |
About Wei Yan
Wei Yan is a scholar working on Clinical Biochemistry, Cancer Research and Molecular Biology, having authored 106 papers that have together received 4.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Extracellular vesicles in disease (18 papers), Advanced Glycation End Products research (15 papers), Alzheimer's disease research and treatments (11 papers), RNA modifications and cancer (10 papers), Diet, Metabolism, and Disease (9 papers), Circular RNAs in diseases (8 papers) and Congenital heart defects research (6 papers). The work is most often cited by research in Clinical Biochemistry (446 citations), Cancer Research (985 citations) and Molecular Biology (2.5k citations). Wei Yan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shuai Jiang, Takashi Mikawa, Shizhen Emily Wang, Rongqiao He, Minghui Cao, Rong He, Ying Liu, Sylvia Μ. Evans, Xiwei Wu and Donald Pizzo. Their work appears in journals such as PLoS ONE, Nature Communications, Development, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.